Fujita Shohei, Gagoski Borjan, Nielsen Jon-Fredrik, Zaitsev Maxim, Jun Yohan, Cho Jaejin, Yong Xingwang, Uhl Quentin, Xu Pengcheng, Milshteyn Eugene, Shaik Imam Ahmed, Liu Qiang, Chen Qingping, Afacan Onur, Kirsch John E, Rathi Yogesh, Bilgic Berkin
Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, Massachusetts, USA.
Department of Radiology, Harvard Medical School, Boston, Massachusetts, USA.
Magn Reson Med. 2025 Sep;94(3):937-948. doi: 10.1002/mrm.30566. Epub 2025 May 26.
To address the unmet need for a cross-platform, multiparametric relaxometry technique to facilitate data harmonization across different sites.
A simultaneous T and T mapping technique, 3D quantification using an interleaved Look-Locker acquisition sequence with a T preparation pulse (3D-QALAS), was implemented using the open-source vendor-agnostic Pulseq platform. The technique was tested on four 3 T scanners from two vendors across two sites, evaluating cross-scanner, cross-software version, cross-site, and cross-vendor variability. The cross-vendor reproducibility was assessed using both the vendor-native and Pulseq-based implementations. A National Institute of Standards and Technology/International Society for Magnetic Resonance in Medicine system phantom and three human subjects were evaluated. The acquired T and T maps from the different 3D-QALAS runs were compared using linear regression, Bland-Altman plots, coefficient of variation (CV), and intraclass correlation coefficient (ICC).
Pulseq-QALAS demonstrated high linearity (R = 0.994 for T, R = 0.999 for T) and correlation (ICC = 0.99 [0.98-0.99]) against temperature-corrected NMR reference values in the system phantom. Compared to vendor-native sequences, the Pulseq implementation showed significantly higher reproducibility in phantom T values (CV, 2.3% vs. 17%; p < 0.001), and improved T reproducibility (CV, 3.4% vs. 4.9%; p = 0.71, not significant). The Pulseq implementation reduced cross-vendor variability to a level comparable to cross-scanner (within-vendor) variability. In vivo, Pulseq-QALAS exhibited reduced cross-vendor variability, particularly for T values in gray matter with a twofold reduction in variability (CV, 2.3 vs. 5.9%; p < 0.001).
An identical implementation across different scanners and vendors, combined with consistent reconstruction and fitting pipelines, can improve relaxometry measurement reproducibility across platforms.
满足对跨平台多参数弛豫测量技术的需求,以促进不同站点间的数据协调。
使用开源的、与供应商无关的Pulseq平台,实施一种同时进行T1和T2映射的技术,即采用带有T1准备脉冲的交错式Look-Locker采集序列进行3D定量(3D-QALAS)。该技术在两个站点的来自两家供应商的四台3T扫描仪上进行测试,评估跨扫描仪、跨软件版本、跨站点和跨供应商的变异性。使用供应商原生和基于Pulseq的实现方式评估跨供应商的可重复性。对美国国家标准与技术研究院/国际医学磁共振学会系统体模和三名人类受试者进行评估。使用线性回归、Bland-Altman图、变异系数(CV)和组内相关系数(ICC)比较不同3D-QALAS运行中获取的T1和T2图谱。
在系统体模中,Pulseq-QALAS与温度校正后的NMR参考值相比,显示出高线性(T1的R = 0.994,T2的R = 0.999)和相关性(ICC = 0.99 [0.98 - 0.99])。与供应商原生序列相比,Pulseq实现方式在体模T1值上显示出显著更高的可重复性(CV,2.3%对17%;p < 0.001),并且T2可重复性有所改善(CV,3.4%对4.9%;p = 0.71,不显著)。Pulseq实现方式将跨供应商变异性降低到与跨扫描仪(供应商内部)变异性相当的水平。在体内,Pulseq-QALAS表现出降低的跨供应商变异性,特别是对于灰质中的T1值,变异性降低了两倍(CV,2.3对5.9%;p < 0.001)。
跨不同扫描仪和供应商的相同实现方式,结合一致的重建和拟合流程,可以提高跨平台弛豫测量的可重复性。